Stock News

Welcome to the Exciting World of Cancer Nanotechnology! Dr. Len Pagliaro Showcases Sona Nanotech’s Targeted Hyperthermia Therapy at NCL Symposium Halifax, Nova Scotia– November 7, 2024 – Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) Hey there, fellow science enthusiasts! Have you heard the latest buzz in the world of cancer research? Sona Nanotech’s Chief Scientific…

Aptevo Therapeutics Inc. Reports Clinical Milestones and Financial Results Business Highlights In the third quarter of 2024, Aptevo Therapeutics Inc. achieved significant milestones in its clinical programs. The company initiated the mipletamig Phase 1b/2 clinical trial, “RAINIER,” in frontline acute myeloid leukemia (AML) patients. This decision was informed by positive results from the dose escalation…

New data for investigational nipocalimab in Sjögren’s Disease (SjD) and new research on the impact of TREMFYA® (guselkumab) in psoriatic arthritis (PsA) Exciting Updates from ACR 2024 Annual Meeting Results from the Phase 2 DAHLIAS study of nipocalimab in SjD show promising outcomes. Nipocalimab has shown to be effective in reducing ClinESSDAI score from baseline…

Exciting News in Weight Loss and Blood Glucose Control Modular Medical’s Groundbreaking Study Reveals Promising Results SAN DIEGO, CA / ACCESSWIRE / November 7, 2024 It’s not every day that we hear about groundbreaking studies that could potentially revolutionize the way we approach weight loss and blood glucose control. Modular Medical, Inc., a leading insulin…

Financial Performance Improvement Driven by Operational Initiatives at Wheels Up Experience Inc. ATLANTA , Nov. 7, 2024 /PRNewswire/ — Wheels Up Experience Inc. (NYSE:UP) today announced financial results for the third quarter, which ended September 30, 2024. Over the past year, Wheels Up Experience Inc. has seen a significant improvement in their financial performance, driven…

U.S. Cellular Strikes Billion-Dollar Deal with AT&T for Spectrum Assets By: [Your Name] CHICAGO, Nov. 7, 2024 /PRNewswire/ — United States Cellular Corporation (NYSE: USM) today has announced that it has entered into an agreement with AT&T (NYSE: T) to sell a portion of the Company’s retained spectrum licenses for total consideration of $1.018 billion….

eXp World Holdings Inc. Under Investigation by Shareholder Rights Advocates Investors, Contact Levi & Korsinsky for Possible Securities Law Violations! NEW YORK, NY / ACCESSWIRE / November 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of eXp World Holdings, Inc. (“eXp World Holdings, Inc.”) (NASDAQ:EXPI) concerning possible violations of…

clonoSEQ Receives Medicare Coverage for MRD Assessment in MCL Introduction Adaptive Biotechnologies Corporation has achieved a significant milestone with clonoSEQ, the first and only assay to receive Medicare coverage for measurable residual disease (MRD) assessment in mantle cell lymphoma (MCL). This decision by Palmetto GBA, a Medicare Administrative Contractor, marks a pivotal moment in the…